Literature DB >> 29524584

Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.

David E Elder1, Michael W Piepkorn2, Raymond L Barnhill3, Gary M Longton4, Heidi D Nelson5, Stevan R Knezevich6, Margaret S Pepe4, Patricia A Carney7, Linda J Titus8, Tracy Onega9, Anna N A Tosteson10, Martin A Weinstock11, Joann G Elmore12.   

Abstract

BACKGROUND: Diagnostic interpretations of melanocytic skin lesions vary widely among pathologists, yet the underlying reasons remain unclear.
OBJECTIVE: Identify pathologist characteristics associated with rates of accuracy and reproducibility.
METHODS: Pathologists independently interpreted the same set of biopsy specimens from melanocytic lesions on 2 occasions. Diagnoses were categorized into 1 of 5 classes according to the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis system. Reproducibility was determined by pathologists' concordance of diagnoses across 2 occasions. Accuracy was defined by concordance with a consensus reference standard. Associations of pathologist characteristics with reproducibility and accuracy were assessed individually and in multivariable logistic regression models.
RESULTS: Rates of diagnostic reproducibility and accuracy were highest among pathologists with board certification and/or fellowship training in dermatopathology and in those with 5 or more years of experience. In addition, accuracy was high among pathologists with a higher proportion of melanocytic lesions in their caseload composition and higher volume of melanocytic lesions. LIMITATIONS: Data gathered in a test set situation by using a classification tool not currently in clinical use.
CONCLUSION: Diagnoses are more accurate among pathologists with specialty training and those with more experience interpreting melanocytic lesions. These findings support the practice of referring difficult cases to more experienced pathologists to improve diagnostic accuracy, although the impact of these referrals on patient outcomes requires additional research.
Copyright © 2018 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  dermatopathology; diagnosis; discordance; melanocytic lesions; melanoma; observer variability; pathologist characteristics

Mesh:

Year:  2018        PMID: 29524584      PMCID: PMC6016831          DOI: 10.1016/j.jaad.2018.02.070

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  23 in total

1.  Dermatologist not equal to dermatopathologist: no place in a profession for pretenders.

Authors:  A Bernard Ackerman
Journal:  J Am Acad Dermatol       Date:  2005-10       Impact factor: 11.527

2.  The reason that dermatologists should not send all their slides to dermatopathologists is a scope of practice argument, not an ethical argument.

Authors:  Ronald Moy
Journal:  J Am Acad Dermatol       Date:  2005-10       Impact factor: 11.527

3.  The MPATH-Dx reporting schema for melanocytic proliferations and melanoma.

Authors:  Michael W Piepkorn; Raymond L Barnhill; David E Elder; Stevan R Knezevich; Patricia A Carney; Lisa M Reisch; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2013-10-28       Impact factor: 11.527

4.  Achieving consensus for the histopathologic diagnosis of melanocytic lesions: use of the modified Delphi method.

Authors:  Patricia A Carney; Lisa M Reisch; Michael W Piepkorn; Raymond L Barnhill; David E Elder; Stevan Knezevich; Berta M Geller; Gary Longton; Joann G Elmore
Journal:  J Cutan Pathol       Date:  2016-07-01       Impact factor: 1.587

5.  Diagnostic concordance among pathologists interpreting breast biopsy specimens.

Authors:  Joann G Elmore; Gary M Longton; Patricia A Carney; Berta M Geller; Tracy Onega; Anna N A Tosteson; Heidi D Nelson; Margaret S Pepe; Kimberly H Allison; Stuart J Schnitt; Frances P O'Malley; Donald L Weaver
Journal:  JAMA       Date:  2015-03-17       Impact factor: 56.272

6.  Variability in mitotic figures in serial sections of thin melanomas.

Authors:  Stevan R Knezevich; Raymond L Barnhill; David E Elder; Michael W Piepkorn; Lisa M Reisch; Gaia Pocobelli; Patricia A Carney; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2014-09-16       Impact factor: 11.527

7.  Discrepancies in dermatopathology diagnoses: the role of second review policies and dermatopathology fellowship training.

Authors:  Sudeep Gaudi; J Manuel Zarandona; Stephen S Raab; Joseph C English; Drazen M Jukic
Journal:  J Am Acad Dermatol       Date:  2012-08-11       Impact factor: 11.527

8.  Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.

Authors:  R Corona; A Mele; M Amini; G De Rosa; G Coppola; P Piccardi; M Fucci; P Pasquini; T Faraggiana
Journal:  J Clin Oncol       Date:  1996-04       Impact factor: 44.544

9.  Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").

Authors:  Raymond L Barnhill; Zsolt Argenyi; Marianne Berwick; Paul H Duray; Lori Erickson; Joan Guitart; Marcello G Horenstein; Lori Lowe; Jane Messina; Susan Paine; Michael W Piepkorn; Victor Prieto; Michael S Rabkin; Birgitta Schmidt; Angelica Selim; Chris R Shea; Martin J Trotter
Journal:  Am J Surg Pathol       Date:  2008-01       Impact factor: 6.394

10.  How concerns and experiences with medical malpractice affect dermatopathologists' perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions.

Authors:  Patricia A Carney; Paul D Frederick; Lisa M Reisch; Stevan Knezevich; Michael W Piepkorn; Raymond L Barnhill; David E Elder; Berta M Geller; Linda Titus; Martin A Weinstock; Heidi D Nelson; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2015-11-11       Impact factor: 11.527

View more
  7 in total

Review 1.  Dermoscopic Criteria, Histopathological Correlates and Genetic Findings of Thin Melanoma on Non-Volar Skin.

Authors:  Cesare Massone; Rainer Hofman-Wellenhof; Stefano Chiodi; Simona Sola
Journal:  Genes (Basel)       Date:  2021-08-23       Impact factor: 4.096

2.  Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.

Authors:  Michael W Piepkorn; Gary M Longton; Lisa M Reisch; David E Elder; Margaret S Pepe; Kathleen F Kerr; Anna N A Tosteson; Heidi D Nelson; Stevan Knezevich; Andrea Radick; Hannah Shucard; Tracy Onega; Patricia A Carney; Joann G Elmore; Raymond L Barnhill
Journal:  JAMA Netw Open       Date:  2019-10-02

Review 3.  Multiplexed Immunohistochemistry and Digital Pathology as the Foundation for Next-Generation Pathology in Melanoma: Methodological Comparison and Future Clinical Applications.

Authors:  Yannick Van Herck; Asier Antoranz; Madhavi Dipak Andhari; Giorgia Milli; Oliver Bechter; Frederik De Smet; Francesca Maria Bosisio
Journal:  Front Oncol       Date:  2021-03-29       Impact factor: 6.244

Review 4.  Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects.

Authors:  Dekker C Deacon; Eric A Smith; Robert L Judson-Torres
Journal:  Front Med (Lausanne)       Date:  2021-04-16

5.  Assessment of a Diagnostic Classification System for Management of Lesions to Exclude Melanoma.

Authors:  Ian Katz; Blake O'Brien; Simon Clark; Curtis T Thompson; Brian Schapiro; Anthony Azzi; Alister Lilleyman; Terry Boyle; Lore Jane L Espartero; Miko Yamada; Tarl W Prow
Journal:  JAMA Netw Open       Date:  2021-12-01

6.  MicroRNA Ratios Distinguish Melanomas from Nevi.

Authors:  Rodrigo Torres; Ursula E Lang; Miroslav Hejna; Samuel J Shelton; Nancy M Joseph; A Hunter Shain; Iwei Yeh; Maria L Wei; Michael C Oldham; Boris C Bastian; Robert L Judson-Torres
Journal:  J Invest Dermatol       Date:  2019-09-30       Impact factor: 8.551

7.  Pigmented Lesion Assay for Suspected Melanoma Lesions: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.